Angiogenesis in breast cancer: How should we measure this? (Review)

  • Authors:
    • M. J.K. Pollitt
    • A.M. Hanby
    • K. Horgan
    • C.E. Murphy
    • P.F. Jones
    • V. Speirs
  • View Affiliations

  • Published online on: Sunday, May 1, 2005
  • Pages: 931-936
  • DOI: 10.3892/or.13.5.931

Abstract

Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.
Journal Cover

May 2005
Volume 13 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

2013 Impact Factor: 2.191
Ranked #33/202 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Pollitt, M., Hanby, A., Horgan, K., Murphy, C., Jones, P., & Speirs, V. (2005). Angiogenesis in breast cancer: How should we measure this? (Review). Oncology Reports, 13(5), 931-936.
MLA
Pollitt, Hanby, Horgan, Murphy, Jones, and V. Speirs. "Angiogenesis in breast cancer: How should we measure this? (Review)." Oncology Reports Oncology Reports 13.5 (2005): 931-936.
Chicago
Pollitt, Hanby, Horgan, Murphy, Jones, and V. Speirs. "Angiogenesis in breast cancer: How should we measure this? (Review)." Oncology Reports Oncology Reports 13 no. 5 (2005): 931-936.